Literature DB >> 19173139

[Post-traumatic cyclodialysis cleft treated with transscleral diode laser].

C D Cerio-Ramsden1, F J Muñoz-Negrete, G Rebolleda.   

Abstract

CASE REPORT: A 28-year-old man who received a blunt trauma in his left eye, presented with persistent ocular hypotony (intraocular pressure: 4 mmHg) as well as loss of visual acuity (0.4), optic disc edema and chorioretinal folds in the macula. The foveal thickness, measured by optic coherence tomography, was 326 microns. Using ultrasound biomicroscopy, a desinsertion of the nasal iris and a 360 degrees choroidal detachment was observed. The hypotony did not respond to conservative treatment and 10 months after the trauma he underwent a transscleral cyclopexy with contact diode laser. One year after the laser treatment the visual acuity was 1.0, the intraocular pressure 14 mmHg and the foveal thickness 240 microns. DISCUSSION: Transscleral cyclopexy with diode laser may be an effective alternative treatment to resolve post-traumatic cyclodialysis that does not respond to medical treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19173139     DOI: 10.4321/s0365-66912009000100008

Source DB:  PubMed          Journal:  Arch Soc Esp Oftalmol        ISSN: 0365-6691


  4 in total

Review 1.  Cyclodialysis: an update.

Authors:  Julio González-Martín-Moro; Inés Contreras-Martín; Francisco José Muñoz-Negrete; Fernando Gómez-Sanz; Jesús Zarallo-Gallardo
Journal:  Int Ophthalmol       Date:  2016-07-08       Impact factor: 2.031

2.  Clinical study on Hypotony following blunt ocular trauma.

Authors:  Chun Ding; Jun Zeng
Journal:  Int J Ophthalmol       Date:  2012-12-18       Impact factor: 1.779

3.  Use of anterior segment imaging and direct cyclopexy repair of cyclodialysis cleft.

Authors:  Chin Sheng Teoh; Maria Cecilia Aquino; Dawn K Lim; Paul Chew; Victor Koh
Journal:  Taiwan J Ophthalmol       Date:  2021-08-17

4.  A novel method for the localization and management of traumatic cyclodialysis cleft.

Authors:  Mingling Wang; Shufang Hu; Zhenquan Zhao; Tianlin Xiao
Journal:  J Ophthalmol       Date:  2014-03-11       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.